Status:

RECRUITING

A Bidirectional Cohort Study of COMMD10 Expression in Tumor Tissues for Predicting Radiosensitivity

Lead Sponsor:

Nanfang Hospital, Southern Medical University

Conditions:

Biomarker

Radiosensitivity

Eligibility:

All Genders

18+ years

Brief Summary

Radiotherapy is one of the main treatments for malignant tumors, and according to authoritative estimates, about 70% of patients with malignant tumors should receive radiotherapy. However, radiation r...

Eligibility Criteria

Inclusion

  • At least 18 years old;
  • Voluntarily sign informed consent;
  • Nasopharyngeal carcinoma, head and neck tumor, lung cancer, breast cancer, stomach cancer, colorectal cancer, glioma, esophageal cancer, liver cancer, bile duct cancer, cervical cancer, prostate cancer confirmed by pathology;
  • Measurable tumor lesions according to RECIST v1.1 criteria;
  • Patients with radiation therapy indications and voluntarily accept radiotherapy;
  • ECOG PS score: 0/1.

Exclusion

  • There are contraindications to radiotherapy;
  • Pathological sections could not be obtained;
  • Presence of metal metabolism-related diseases such as Wilson's disease;
  • Merge other tumors (has cured basal cell or squamous cell cancer, and cervical cancer in situ except 5);
  • Patients had any serious coexisting medical conditions that could pose an unacceptable risk or negatively affect trial adherence. "For example, unstable heart disease requiring treatment, chronic hepatitis, kidney disease, poor health status, uncontrolled diabetes (fasting blood glucose \> 1.5 × ULN), and mental illness;"
  • The investigator judged that he was not suitable to participate in the study.

Key Trial Info

Start Date :

December 1 2023

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

June 30 2025

Estimated Enrollment :

400 Patients enrolled

Trial Details

Trial ID

NCT06165224

Start Date

December 1 2023

End Date

June 30 2025

Last Update

March 15 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Nanfang hospital, Southern medical university

Guangzhou, Guangdong, China, 510515